Alterity Therapeutics (ATHE) Payables (2009 - 2025)

Alterity Therapeutics' Payables history runs 17 years deep, the most recent figure standing at $1.0 million for Q4 2025.

• On a quarterly basis, Payables fell 21.85% year-over-year to $1.0 million in Q4 2025; TTM through Dec 2025 was $1.0 million, a 21.85% decrease from a year earlier, with the FY2025 full-year figure at $1.6 million, down 45.83% from the prior year.
• Payables slipped to $1.0 million in Q4 2025 per ATHE's latest filing, from $1.6 million in the prior quarter.
• Across five years, Payables topped out at $3.6 million in Q2 2022 and bottomed at $35177.1 in Q2 2023.
• The 5-year median for Payables is $1.8 million (2021), against an average of $1.7 million.
• Across the five-year window, Payables slumped 99.03% in 2023 and jumped 3470.23% in 2025, its largest moves.
• Year by year, Payables stood at $2.3 million in 2021, then increased by 27.9% to $2.9 million in 2022, then declined by 19.05% to $2.4 million in 2023, then plunged by 43.27% to $1.3 million in 2024, then dropped by 21.85% to $1.0 million in 2025.
• Per Business Quant, the three latest ATHE Payables figures stand at $1.0 million (Q4 2025), $1.6 million (Q2 2025), and $1.3 million (Q4 2024).